Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
32%
OVERLAP
BY WEIGHT
23
# OF OVERLAPPING
HOLDINGS
XBI
120
HOLDINGS
20%
ALSO IN PBE
PBE
28
HOLDINGS
82%
ALSO IN XBI
SECTOR DRIFT (XBI minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 2.0% | 4.8% | 2.0% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.0% | 2.7% | 2.0% |
|
EXACT SCIENCES CORP | 2.0% | 3.1% | 2.0% |
|
AMGEN INC | 1.9% | 4.8% | 1.9% |
|
INCYTE CORP | 1.9% | 4.8% | 1.9% |
XBI Overweight Relative to PBE
|
AVIDITY BIOSCIENCES INC | 2.5% |
|
REVOLUTION MEDICINES, INC. | 2.4% |
|
INSMED INC | 2.1% |
|
BRIDGEBIO PHARMA, INC. | 2.0% |
|
NATERA INC | 1.9% |
 |
ROIVANT SCIENCES LTD. | 1.9% |
|
ABBVIE INC | 1.8% |
|
MODERNA, INC. | 1.6% |
|
CRISPR THERAPEUTICS AG | 1.6% |
|
VIKING THERAPEUTICS, INC. | 1.6% |
XBI Underweight Relative to PBE
|
ILLUMINA INC | -4.8% |
|
ROYALTY PHARMA PLC CLASS A | -4.7% |
|
BIOGEN IDEC INC | -3.6% |
|
VERTEX PHARMACEUTICALS INC | -3.1% |
|
INCYTE CORP | -2.9% |
|
AMGEN INC | -2.9% |
|
GILEAD SCIENCES INC | -2.9% |
|
BIO-TECHNE CORPORATION | -2.8% |
|
REGENERON PHARMACEUTICALS | -2.8% |
|
SAREPTA THERAPEUTICS INC | -2.5% |